High Response Rate to Bexxar in Advanced Stage Prior Treatment-Resistant Follicular Lymphoma

A new form of treatment for lymphoma that takes a fraction of the time of traditional chemotherapy with fewer side effects caused tumors to shrink in 95 percent of patients, a new study by researchers at the University of Michigan Comprehensive Cancer Center found.Patients with advanced-stage follicular lymphoma - a cancer generally considered incurable - who had not been previously treated with any other form of therapy received a single course...